IDSA/ATS TB Guidelines Cover

Drug-Susceptible Tuberculosis GUIDELINES Pocket Guide

Approved By

American Thoracic Society

Infectious Diseases Society of America

Digital Subscription $4.99 Add to Cart
Print $11.95 Add to Cart
Free Sample

Published: August 2016

The digital version of the ATS/IDSA Drug-Susceptible Tuberculosis GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:

  • For a single low price: $4.99
  • Includes automatic updates on drugs and indications
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on mobile apps accessible without an internet connection
  • Including off-line access to thousands of guideline summaries and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Drug-Susceptible Tuberculosis GUIDELINES Pocket Guide is based on the latest guidelines of the Infectious Diseases Society of America (IDSA) and the American Thoracic Society and was developed with their collaboration. This practical quick-reference tool contains graded recommendations for treating drug-susceptible tuberculosis including regimens with dosing, compliance monitoring and follow-up.

  • Spiral-Bound
  • 24 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points 
  • Recommended Treatment Regimens
  • Treatment in Special Situations 
  • Figures 
    • Factors to be considered in deciding to initiate treatment empirically for active tuberculosis
    • Baseline And Follow-Up Evaluations For Patients Treated With First-Line Tuberculosis Medications 
  • Tables 
    • Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis Caused by Drug-Susceptible Organisms
    • Doses of Antituberculosis Drugs for Adults and Children 
    • Possible Components of a Multifaceted, Patient-Centered Treatment Strategy
    • Examples of Priority Situations for the Use of Directly Observed Therapy
    • Management of Treatment Interruptions
    • Other Causes of Abnormal Liver Function Tests That Should Be Excluded
    • Conditions or Situations in Which Therapeutic Drug Monitoring May Be Helpful
    • Clinically Significant Drug–Drug Interactions Involving the Rifamycins
    • Suggested Pyrazinamide Doses, Using Whole Tablets, for Adults Weighing 40–90 kg
    • Suggested Ethambutol Dosages, Using Whole Tablets, for Adults Weighing 40–90 kg
    • Dosing Recommendations for Adult Patients With Reduced Renal Function

The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account